Pharmaceutical company in the
Canton of Basel-Country

Basilea Pharmaceutica AG, Allschwil

Since 2002 · 101–500 empl.·4.5(2)

Basilea Pharmaceutica AG, Allschwil develops and commercializes medicines for serious bacterial and fungal infections. The biopharmaceutical company markets Cresemba and Zevtera and develops additional anti-infective drug candidates.

Novartis Pharma Schweizerhalle AG

Since 1938 · 21–50 empl.

Novartis Pharma Schweizerhalle AG is a Novartis production site for chemical active substances and intermediates. The site carries out complex manufacturing processes, laboratory analysis and release for further processing within the production network.

Dr. Grossmann AG, Pharmaca

Since 1977 · 1–10 empl.

Dr. Grossmann AG, Pharmaca manufactures and distributes pharmaceutical preparations. Its range includes vitamin supplements, cough and cold medicines, anti-inflammatory drugs, antibiotics and products for other medical indications; the preparations are manufactured in accordance with GMP guidelines.

Merz Pharma (Schweiz) AG

Since 1977 · 51–100 empl.

The core activity of Merz Therapeutics is the development, manufacture and marketing of pharmaceuticals, particularly in the fields of neurology, hepatology and dermatology. The company focuses on researching and developing innovative therapies to improve the quality of life for patients.

CARBOGEN AMCIS AG

Since 1982 · 101–500 empl.

CARBOGEN AMCIS AG is a contract development and manufacturing organisation serving the pharmaceutical and biopharmaceutical industries. It develops and manufactures active pharmaceutical ingredients and drug products, supporting projects from early development through commercial supply, and also produces cholesterol and vitamin D derivatives.

Pharmatrans Sanaq AG

Since 1982 · 11–20 empl.

Pharmatrans Sanaq AG specializes in excipients and active ingredients for the pharmaceutical industry. It supplies products and customized solutions, and provides services including sourcing, packaging, storage and distribution.

Andreabal AG

Since 1988 · 11–20 empl.

The core activity of Andreabal AG is the development, manufacture and distribution of products for women before, during and after pregnancy, including pregnancy preparation, breastfeeding and menopause, as well as vitamins, iron deficiency and skin and nail care products.

Abbott Laboratories GmbH

Since 1989 · 51–100 empl.

Abbott Laboratories GmbH represents the Abbott group and provides services for the sale and marketing of its products. Its areas of activity in Switzerland include pharmaceuticals, diagnostics, diabetes care, medical nutrition, and cardiovascular therapies.

Curatis AG

Since 1993 · 21–50 empl.

Curatis AG is a specialty pharmaceutical company that acquires, develops and commercialises medicines for rare diseases and specialty care. It distributes its own products and those of partner companies and develops drug candidates for these medical indications.

Medius AG

Since 1997 · 1–10 empl.

Medius AG is a service and consulting company for regulatory affairs and quality management in the pharmaceutical sector. Its services include support with marketing authorisation applications and product life-cycle management, quality management systems, pharmacovigilance and other responsible-person functions.

Desitin Pharma GmbH

Since 1997 · 11–20 empl.

Desitin Pharma GmbH is a pharmaceutical company specialising in medicines for the treatment of epilepsy. It distributes oral and parenteral antiepileptic medicines and provides information about its products.

Actelion Pharmaceuticals Ltd

Since 1997 · 21–50 empl.

Actelion Pharmaceuticals Ltd is a pharmaceutical company focused on the research, development, and marketing of medicines. The website presents Johnson & Johnson Innovative Medicine’s therapeutic areas, including oncology, immunology, neuroscience, and cardiopulmonary care.

ADD Advanced Drug Delivery Technologies Ltd

Since 1998 · 1–10 empl.

ADD Advanced Drug Delivery Technologies Ltd develops and supplies pharmaceutical drug-delivery systems and preparations. Its offerings include technologies for taste masking and for improving the processing and solubility of active ingredients, as well as custom formulation services.

SynphaBase AG

Since 2000 · 11–20 empl.

SynphaBase AG develops and synthesizes complex bioorganic molecules for pharmaceutical and biotechnology applications, including glycans, peptides, RNA building blocks and conjugates. Its services include synthesis route design, process optimization, scale-up, and the manufacture and supply of active ingredients and reference materials, including GMP material for early clinical phases.

Protzek Biotec GmbH

Since 2003 · 11–20 empl.

Protzek Biotec GmbH develops and supplies diagnostic tests and mobile PIA analysis systems for viral and drug screening. Its products include tests for different sample types and the GreenCheck range, designed to reduce plastic use.

Amacom GmbH

Since 2003 · 1–10 empl.

Amacom GmbH provides a butler service for everyday tasks, including shopping, transport, errands and coordinating appointments with tradespeople or technicians. Its offerings also include products made with natural mineral clay.

Herbonis AG

Since 2004 · 51–100 empl.

Herbonis AG develops and produces natural specialty feed ingredients and products for animal nutrition. Its range includes products based on Solanum glaucophyllum leaves, intended to support vitamin D metabolism and calcium balance in livestock.

Xenometrix AG

Since 2005 · 1–10 empl.

Xenometrix AG develops and supplies bioassay kits and components, particularly for miniaturized Ames tests and the detection of endocrine-active substances. It also provides analytical services for mutagenicity, genotoxicity, endocrine activity and dermal permeation.

Thermo Fisher Diagnostics AG

Since 2006 · 101–500 empl.

Thermo Fisher Diagnostics AG supplies diagnostic instruments, reagents, consumables, software and related services for clinical laboratories and life‑science research. Its portfolio includes laboratory equipment and analytical systems for sample and material characterization, chemical analysis and clinical diagnostics.

Baliopharm AG

Since 2007 · 1–10 empl.

Baliopharm AG develops monoclonal and bispecific antibody therapeutics for chronic liver diseases, immune-mediated inflammatory diseases and cancer. Its drug candidates include Atrosab, Atrosimab and Novotarg.

EpiPharm AG

Since 2007 · 1–10 empl.

EpiPharm AG develops pharmaceutical and dermato-cosmetic products for skin disorders and other skin needs. Its work includes research into artemisinin-based active ingredients and the development of topical therapies and skincare products.

Thermo Fisher Scientific (Schweiz) AG

Since 2008 · 101–500 empl.

Thermo Fisher Scientific (Schweiz) AG supplies scientific instruments, reagents, consumables, software and services for research, diagnostics, biopharma and industrial laboratories. Its portfolio includes laboratory equipment, antibodies and assays, contract development and manufacturing (CDMO/CRO) services, instrument support and lab informatics solutions.

Cederberg GmbH

Since 2008 · 1–10 empl.

Cederberg GmbH is an international healthcare company focused on developing and commercialising patent-protected medicines and medical devices. Its activities include speciality prescription pharmaceuticals and medical devices for areas such as gastroenterology, gynaecology, urology and endocrinology, and commercial products include Moventig®, Tostran®, Rectogesic® and Gynomunal®.

Drug'On Pharma Switzerland AG

Since 2009 · 1–10 empl.

Drug'On Pharma Switzerland AG is part of the Orofino Pharmaceuticals group and operates a chemical production site manufacturing active pharmaceutical ingredients (APIs) and intermediates. The site comprises four production buildings and provides chemical manufacturing capabilities for APIs and intermediates.

Probiocon GmbH

Since 2012 · 1–10 empl.

Probiocon GmbH advises pharmaceutical and biotechnology companies on corporate development and strategy, including financing, business development, licensing and partnering, and mergers and acquisitions. It also provides technical project management and outsourcing support for CMC development and manufacturing activities.

Opterion Health AG

Since 2012 · 11–20 empl.

Opterion Health AG researches and develops therapies for chronic kidney disease. Its main development is OPT101, a non-glucose-based product for peritoneal dialysis being developed as an alternative to glucose-based dialysis solutions.

INOFEA AG

Since 2014 · 11–20 empl.

INOFEA AG develops biotechnology-based enzyme solutions for manufacturing biologics, including mRNA and antibody-drug conjugates, and pharmaceutical active ingredients. Its patented technology immobilizes and shields enzymes to improve their stability and enable their use in continuous or flow-through processes.

T3 Pharmaceuticals AG

Since 2015 · 11–20 empl.

The core activity of T3 Pharmaceuticals AG is the development of anti-cancer drugs, particularly through the research and development of innovative therapeutics based on microbial pathogenesis and immunotherapy. The company focuses on the discovery and development of new active substances (NCEs) and the clinical development of targeted therapeutics, especially in the fields of oncology and hematology.

DXC RT AG

Since 2015 · 1–10 empl.

DXC RT AG is a biotechnology company that develops and produces plant root cultures and botanical biomass. Its R&D services range from feasibility studies to pilot production, with a focus on Swiss alpine plants and plants used in Traditional Chinese Medicine.

Accord Healthcare AG

Since 2016 · 11–20 empl.

Accord Healthcare AG is a pharmaceutical company supplying medicines and related services in Switzerland. Its portfolio includes generic medicines, biosimilars and branded medicines, with a focus on oncology, haematology, autoimmune and central nervous system conditions.

Valerius Biopharma AG

Since 2017 · 1–10 empl.

Valerius Biopharma AG develops biosimilars and manages a portfolio of orphan and non‑orphan candidates, conducting R&D on cell lines, process development and extensive analytical characterization.

saverna therapeutics AG

Since 2017 · 1–10 empl.

saverna therapeutics AG is a drug discovery and development company focused on small-molecule drugs targeting non-coding RNA, particularly microRNAs. Its platform combines fragment-based screening, nuclear magnetic resonance spectroscopy and machine learning, with research focused on areas including inflammatory and autoimmune diseases, cancer and infections.

acovos AG

Since 2017 · 1–10 empl.

acovos AG supplies human tissue samples for medical research and the development of drugs and diagnostics. Its products include FFPE tissue samples, matched normal and tumour tissue pairs, and samples pre-tested for specific antibodies.

Premark Pharma GmbH

Since 2018 · 21–50 empl.

Premark Pharma GmbH develops pharmaceutical products, focusing on topical treatments for inflammatory conditions of the skin, eyes and mucosal surfaces. Its development projects include pimecrolimus formulations for blepharitis, dry eye and inflammation of the ocular surface.

Gigabases Switzerland AG

Since 2018 · 1–10 empl.

Gigabases Switzerland AG is a synthetic biology company offering a platform to search for and design proteins in 3D. Designed protein sequences can be converted into orderable expression plasmids, with options for expression in mammalian, bacterial and viral systems.

CAPTOR THERAPEUTICS GmbH

Since 2018 · 11–20 empl.

CAPTOR THERAPEUTICS GmbH is a biopharmaceutical company researching and developing medicines using targeted protein degradation. Its drug discovery programmes include targets for cancer and autoimmune diseases.

AlphaMol Science AG

Since 2019 · 1–10 empl.

AlphaMol Science AG is a biotechnology company developing therapeutics targeting G protein-coupled receptors (GPCRs). Its discovery platform combines computational drug design and artificial intelligence with structural biology, medicinal chemistry and experimental pharmacology, with programs in immunology, metabolic disease and pain.

Alloy Therapeutics (Switzerland) AG

Since 2019 · 21–50 empl.

Alloy Therapeutics (Switzerland) AG develops and provides technologies and services for drug discovery and development. Its activities focus on antibodies and multispecifics, TCR mimics, genetic medicines, pharmacology, and AI/ML-enabled platforms.